Scott Solomon

Scott Solomon

Harvard University

H-index: 190

North America-United States

About Scott Solomon

Scott Solomon, With an exceptional h-index of 190 and a recent h-index of 142 (since 2020), a distinguished researcher at Harvard University, specializes in the field of Cardiovascular Medicine.

His recent articles reflect a diverse array of research interests and contributions to the field:

Left Ventricular Ejection Fraction and the Future of Heart Failure Phenotyping

ELECTRONIC NUDGES TO INCREASE INFLUENZA VACCINATION UPTAKE AMONG PARTICIPANTS WITH HISTORY OF ACUTE MYOCARDIAL INFARCTION: INSIGHTS FROM NUDGE-FLU

Effects of high‐dose versus standard‐dose quadrivalent influenza vaccine among patients with diabetes: A post‐hoc analysis of the DANFLU‐1 trial

Angiotensin receptor-neprilysin inhibition in patients with STEMI vs NSTEMI

Cause-Specific Healthcare Costs Following Hospitalization for Heart Failure and Cost Offset with SGLT2 Inhibitor Therapy

Efficacy and Safety of aficamten in Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy: Results From the REDWOOD-HCM Trial, Cohort 4

High‐Dose vs. Standard‐Dose Influenza Vaccine and Cardiopulmonary Hospitalization or Mortality: Emulating the INVESTED Trial Using Insurance Claims Data

Efficacy And Safety Of Sacubitril/valsartan In Patients Hospitalized With Heart Failure: A Prespecified, Pooled Individual Patient-level Analysis Of PIONEER-HF And PARAGLIDE-HF

Scott Solomon Information

University

Position

Brigham and Women's Hospital

Citations(all)

281504

Citations(since 2020)

141699

Cited By

188643

hIndex(all)

190

hIndex(since 2020)

142

i10Index(all)

922

i10Index(since 2020)

807

Email

University Profile Page

Harvard University

Google Scholar

View Google Scholar Profile

Scott Solomon Skills & Research Interests

Cardiovascular Medicine

Top articles of Scott Solomon

Title

Journal

Author(s)

Publication Date

Left Ventricular Ejection Fraction and the Future of Heart Failure Phenotyping

Matthew G Dimond

Nasrien E Ibrahim

Mona Fiuzat

John JV McMurray

JoAnn Lindenfeld

...

2024/3/1

ELECTRONIC NUDGES TO INCREASE INFLUENZA VACCINATION UPTAKE AMONG PARTICIPANTS WITH HISTORY OF ACUTE MYOCARDIAL INFARCTION: INSIGHTS FROM NUDGE-FLU

Journal of the American College of Cardiology

Ankeet Bhatt

Niklas Dyrby Johansen

Daniel Modin

Brian Claggett

Safia Chatur

...

2024/4/2

Effects of high‐dose versus standard‐dose quadrivalent influenza vaccine among patients with diabetes: A post‐hoc analysis of the DANFLU‐1 trial

Diabetes, Obesity and Metabolism

Mats C Højbjerg Lassen

Niklas Dyrby Johansen

Daniel Modin

Joshua Nealon

Sandrine Samson

...

2024/5

Angiotensin receptor-neprilysin inhibition in patients with STEMI vs NSTEMI

The Journal of Heart and Lung Transplantation

S Alishetti

GM Mondellini

L Braghieri

A Javaid

KL Antler

...

2020/4/1

Cause-Specific Healthcare Costs Following Hospitalization for Heart Failure and Cost Offset with SGLT2 Inhibitor Therapy

JACC: Heart Failure

Veraprapas Kittipibul

Muthiah Vaduganathan

Uchechukwu Ikeaba

Karen Chiswell

Javed Butler

...

2024/4/6

Efficacy and Safety of aficamten in Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy: Results From the REDWOOD-HCM Trial, Cohort 4

Journal of Cardiac Failure

Ahmad Masri

Mark V Sherrid

Theodore P Abraham

Lubna Choudhury

Pablo Garcia-Pavia

...

2024/3/15

High‐Dose vs. Standard‐Dose Influenza Vaccine and Cardiopulmonary Hospitalization or Mortality: Emulating the INVESTED Trial Using Insurance Claims Data

Clinical Pharmacology & Therapeutics

Mehdi NajafZadeh

HoJin Shin

Sebastian Schneeweiss

Shirley V Wang

Scott D Solomon

...

2024/1

Efficacy And Safety Of Sacubitril/valsartan In Patients Hospitalized With Heart Failure: A Prespecified, Pooled Individual Patient-level Analysis Of PIONEER-HF And PARAGLIDE-HF

Journal of Cardiac Failure

David A Morrow

Eric Velazquez

Akshay Desai

Adam DeVore

Serge Lepage

...

2024/1/1

Sacubitril/Valsartan-Related Hypotension in Patients with Heart Failure and Preserved or Mildly Reduced Ejection Fraction

Journal of the American College of Cardiology

Alberto Foà

Muthiah Vaduganathan

Brian L Claggett

Maria A Pabon

Henri Lu

...

2024/3/25

Natural language processing for adjudication of heart failure in a multicenter clinical trial: a secondary analysis of a randomized clinical trial

JAMA cardiology

Jonathan W Cunningham

Pulkit Singh

Christopher Reeder

Brian Claggett

Pablo M Marti-Castellote

...

2024

Dapagliflozin and Mode of Death in Heart Failure With Improved Ejection Fraction: A Post Hoc Analysis of the DELIVER Trial

JAMA cardiology

Orly Vardeny

Akshay S Desai

Pardeep S Jhund

James C Fang

Brian Claggett

...

2024/1/24

Cost Effectiveness of Dapagliflozin for Heart Failure Across the Spectrum of Ejection Fraction: An Economic Evaluation Based on Pooled, Individual Participant Data From the …

Journal of the American Heart Association

Ankeet S Bhatt

Muthiah Vaduganathan

Brian L Claggett

Ian J Kulac

Inder S Anand

...

2024/2/23

Effects of High-Dose vs. Standard-Dose Quadrivalent Influenza Vaccine Among Patients with Diabetes: A Post-Hoc Analysis of the DANFLU-1 Trial

Journal of the American College of Cardiology

Mats Lassen

Niklas Dyrby Johansen

Daniel Modin

Joshua Nealon

Matthew Loiacono

...

2024/4/2

High-sensitivity C-reactive protein in heart failure with preserved ejection fraction: Findings from TOPCAT

International Journal of Cardiology

João Pedro Ferreira

Brian L Claggett

Jiankang Liu

Abhinav Sharma

Akshay S Desai

...

2024/2/1

EFFECTS OF SACUBITRIL/VALSARTAN IN PATIENTS WITH HEART FAILURE ACROSS THE SPECTRUM OF KIDNEY RISK

Journal of the American College of Cardiology

Safia Chatur

Brian Claggett

Finnian Mc Causland

Milton Packer

Akshay S Desai

...

2024/4/2

OBESITY AND ADVERSE CARDIAC REMODELING IN HFPEF: THE PARAGON-HF TRIAL

Journal of the American College of Cardiology

Xiaowen Wang

John Ostrominski

Sheldon E Litwin

Maja Cikes

Bela Merkely

...

2024/4/2

IMPACT OF PATISIRAN ON OUTPATIENT HEART FAILURE WORSENING IN PATIENTS WITH CARDIAC TRANSTHYRETIN AMYLOIDOSIS: RESULTS FROM THE APOLLO-B TRIAL

Journal of the American College of Cardiology

Marianna Fontana

Mathew S Maurer

Julian David Gillmore

Shaun Bender

Patrick Y Jay

...

2024/4/2

Atrial Shunt Device Effects on Cardiac Structure and Function in Heart Failure With Preserved Ejection Fraction: The REDUCE LAP-HF II Randomized Clinical Trial

JAMA cardiology

Ravi B Patel

Frank E Silvestry

Jan Komtebedde

Scott D Solomon

Gerd Hasenfuß

...

2024/4/17

Tricuspid regurgitation and clinical outcomes in heart failure with reduced ejection fraction

Heart Failure

Marianna Adamo

Marco Metra

Brian L Claggett

Zi Michael Miao

Rafael Diaz

...

2024/3/1

Dapagliflozin and Timing of Prior Heart Failure Hospitalization: A Patient-Level Meta-Analysis of DAPA-HF and DELIVER

JACC: Heart Failure

Jawad H Butt

Pardeep S Jhund

Kieran F Docherty

Brian L Claggett

Muthiah Vaduganathan

...

2024/4/3

See List of Professors in Scott Solomon University(Harvard University)

Co-Authors

H-index: 237
John McMurray

John McMurray

University of Glasgow

H-index: 150
Milton Packer

Milton Packer

Baylor University

H-index: 146
Rouleau J

Rouleau J

Université de Montréal

H-index: 146
Marc S. Sabatine

Marc S. Sabatine

Harvard University

H-index: 112
Sanjiv J. Shah

Sanjiv J. Shah

Northwestern University

academic-engine